About PTCA Balloon Catheter
PTCA is a minimally invasive procedure to open up blocked coronary arteries to permit unhindered blood flow to the heart muscle. In this procedure, catheters are positioned within the arteries to compress the plaques within a clogged coronary artery. A PTCA balloon catheter is a type of soft catheter equipped with a tiny inflatable balloon at its tip, which is inserted during a catheterization procedure into an artery that has been constricted by the addition of fatty deposits. The balloon is then bloated to clear the blockage and widen the artery. PTCA balloon catheters were the first devices used in the field of interventional cardiology. These catheters are also employed in the positioning of stents during angioplasty. PTCA balloon catheters are used in the PTCA procedures to compress the plaques within a blocked coronary artery.
Technavio's analysts forecast the global PTCA balloon catheter market to grow at a CAGR of 3.48% during 2014-2019.
Covered in this Report
The report includes the present scenario and the growth prospects of the global PTCA balloon catheter market for 2015-2019. The market can be segmented into four divisions: normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, and scoring balloon catheter. To calculate the market size, we consider the revenue generated from these PTCA balloon catheters.
Technavio's report, Global PTCA Balloon Catheter Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Abbott Laboratories
• Boston Scientific
• Medtronic
• Terumo
Other Prominent Vendor
• Aachen Resonance
• Acrostak
• Alvimedica
• AngioScore
• Arthesys
• Asahi Intecc
• Atrium Medical
• B. Braun Melsungen
• Biosensors International
• BIOTRONIK
• C.R. Bard
• Cook Medical
• Cordis
• MicroPort Scientific
• Natec Medical
• Smiths Medical
• Terumo Medical
• Tokai Medical Products
• Volcano
Market Driver
• Growing Aging, Diabetic, and Obese Population
• For a full, detailed list, view our report
Market Challenge
• Availability of Alternative Therapies
• For a full, detailed list, view our report
Market Trend
• Increased Demand for Minimally Invasive Procedures
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. PTCA: An Overview
07.1 About PTCA
07.1.1 Background
07.1.2 Definition
07.1.3 Steps Involved in PTCA
07.1.4 Advantages of PTCA
07.1.5 Complications and Risks Involved in PTCA
07.1.6 PTCA Balloon Catheters Affected Individuals
07.2 PTCA Balloon Catheter Materials
07.2.1 Comparison of Catheter Materials
07.3 Complications of Catheterization
07.3.1 Background
07.3.2 Causes of Complications
08. Market Segmentation by Product Type
08.1 Normal Balloon Catheter
08.2 Drug Eluting Balloon Catheter
08.3 Cutting Balloon Catheter
08.4 Scoring Balloon Catheter
09. Geographical Segmentation
09.1 PTCA Balloon Catheter Market in Americas
09.1.1 Market Size and Forecast
09.2 PTCA Balloon Catheter Market in EMEA
09.2.1 Market Size and Forecast
09.3 PTCA Balloon Catheter Market in APAC
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and Their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and Their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 Abbott Laboratories
17.2.2 Boston Scientific
17.2.3 Medtronic
17.2.4 Terumo
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Abbott Laboratories Inc.
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Business Segmentation
18.1.4 Business Strategy
18.1.5 Revenue by Business Segmentation
18.1.6 Revenue Comparison 2011 and 2012
18.1.7 Revenue by Geographical Segmentation
18.1.8 Key Information
18.1.9 SWOT Analysis
18.2 Boston Scientific
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Key Products
18.2.4 Key Products in Cardiovascular Segment
18.2.5 Key Products in MedSurg Segment
18.2.6 Key Products in Rhythm Management Segment
18.2.7 Business Segmentation by Revenue 2013
18.2.8 Business Segmentation by Revenue 2012 and 2013
18.2.9 Geographical Segmentation by Revenue 2013
18.2.10 Business Strategy
18.2.11 Recent Developments
18.2.12 SWOT Analysis
18.3 Medtronic
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Key Products
18.3.4 Business Segmentation by Revenue 2014
18.3.5 Cardiac and Vascular Group Segmentation by Revenue 2014
18.3.6 Restorative Therapies Group Segmentation by Revenue 2014
18.3.7 Diabetes Group Segmentation by Revenue 2014
18.3.8 Business Segmentation by Revenue 2013 and 2014
18.3.9 Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
18.3.10 Restorative Therapies Group Segmentation by Revenue 2013 and 2014
18.3.11 Diabetes Group Segmentation by Revenue 2013 and 2014
18.3.12 Geographical Segmentation by Revenue 2014
18.3.13 Business Strategy
18.3.14 Key Developments
18.3.15 SWOT Analysis
18.4 Terumo Corp.
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation
18.4.4 Revenue Segmentation by Business
18.4.5 Business Segment Revenue Comparison - FY2011 and FY2012
18.4.6 Revenue Segmentation by Geography
18.4.7 Business Strategy
18.4.8 Key Developments
18.4.9 SWOT Analysis
19. Other Reports in this Series
List Of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global PTCA Balloon Catheter Market 2014-2019 ($ millions)
Exhibit 3: Various Steps of PTCA
Exhibit 4: PTCA Balloon Catheter Materials
Exhibit 5: Common HAIs in Acute Care Settings
Exhibit 6: Major PTCA Balloon Catheter Complications
Exhibit 7: Segmentation of Global PTCA Balloon Catheter Market by Product Type
Exhibit 8: Segmentation of Global PTCA Balloon Catheter by Product Type 2014
Exhibit 9: Segmentation of Global PTCA Balloon Catheter Market by Geography 2014-2019
Exhibit 10: PTCA Balloon Catheter Market in Americas 2014-2019 ($ millions)
Exhibit 11: PTCA Balloon Catheter Market in EMEA 2014-2019 ($ millions)
Exhibit 12: PTCA Balloon Catheter Market in APAC 2014-2019 ($ millions)
Exhibit 13: Segmentation of Global PTCA Balloon Catheter Market by Geography 2014-2019
Exhibit 14: Segmentation of Global PTCA Balloon Catheter Market by Geography 2014-2019
Exhibit 15: Percentage of Elderly Aged Above 65 in Different Regions or Countries 2012 and 2050
Exhibit 16: Abbott Laboratories: Key Takeaways
Exhibit 17: Boston Scientific: Key Takeaways
Exhibit 18: Medtronic: Key Takeaways
Exhibit 19: Terumo: Key Takeaways
Exhibit 20: Abbott Laboratories Inc.: Business Segmentation
Exhibit 21: Abbott Laboratories Inc.: Revenue by Business Segmentation 2012
Exhibit 22: Abbott Laboratories Inc.: Revenue by Business Segmentation 2011 and 2012 ($ million)
Exhibit 23: Abbott Laboratories Inc.: Revenue by Geographical Segmentation 2012
Exhibit 24: Boston Scientific: Key Products in Cardiovascular Segment
Exhibit 25: Boston Scientific: Key Products in MedSurg Segment
Exhibit 26: Boston Scientific: Key Products in Rhythm Management Segment
Exhibit 27: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 28: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 29: Boston Scientific: Geographical Segmentation by Revenue 2013
Exhibit 30: Medtronic: Key Products
Exhibit 31: Medtronic: Business Segmentation by Revenue 2014
Exhibit 32: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
Exhibit 33: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
Exhibit 34: Medtronic: Diabetes Group Segmentation by Revenue 2014
Exhibit 35: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 36: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 37: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 38: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 39: Medtronic: Geographical Segmentation by Revenue 2014
Exhibit 40: Business Segmentation of Terumo Corp.
Exhibit 41: Revenue Segmentation of Terumo Corp.
Exhibit 42: Revenue Comparison of Business Segments ($ billion)
Exhibit 43: Revenue Segmentation by Geography FY2012
